Oral D/L-3-Hydroxybutyrate Stimulates Cholecystokinin and Insulin Secretion and Slows Gastric Emptying in Healthy Males

Nikolaj Rittig, Mads Svart, Henrik Holm Thomsen, Esben Thyssen Vestergaard, Jens Frederik Rehfeld, Bolette Hartmann, Jens Juul Holst, Mogens Johannsen, Niels Møller, Niels Jessen

Research output: Contribution to journalJournal articleResearchpeer-review

17 Citations (Scopus)

Abstract

BACKGROUND: D-3-hydroxybutyrate (D-3-OHB) is a ketone body that serves as an alternative nutritional fuel but also as an important signaling metabolite. Oral ketone supplements containing D/L-3-OHB are becoming a popular approach to achieve ketosis.

AIM: To explore the gut-derived effects of ketone supplements.

METHODS: Eight healthy lean male volunteers were investigated on 2 separate occasions:An acetaminophen test was performed to evaluate gastric emptying and blood samples were obtained consecutively throughout the study period.

RESULTS: We show that oral consumption of D/L-3-OHB stimulates cholecystokinin release (P = 0.02), elevates insulin (P = 0.03) and C-peptide (P < 0.001) concentrations, and slows gastric emptying (P = 0.01) compared with matched intravenous D/L-3-OHB administration. Measures of appetite and plasma concentrations of glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) were unaffected by interventions.

CONCLUSION: Our findings show that D/L-3-OHB exert incretin effects and indicate luminal sensing in the gut endothelium. This adds to our understanding of ketones as signaling metabolites and displays the important difference between physiological ketosis and oral ketone supplements.

Original languageEnglish
Article numberdgaa483
JournalJournal of Clinical Endocrinology and Metabolism
Volume105
Issue number10
Number of pages9
ISSN0021-972X
DOIs
Publication statusPublished - 2020

Cite this